日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A framework for assessing global health impacts of polar change: An urgent call for interdisciplinary research

评估极地变化对全球健康影响的框架:迫切呼吁开展跨学科研究

Naik, Netra; Bot, Karol; Whiteman, Gail; Fleming, Lora E; Morrissey, Karyn; Bellerby, Richard Garth James; Dupont, Sam; Yumashev, Dmitry; Hancock, Susana; Rogers, Brendan M; Ebi, Kristie L; Rocklöv, Joacim

Black, Asian and Minority Ethnic men's experiences of gender-based violence, help-seeking behaviours and psychosocial interventions in the United Kingdom: a systematic review

英国黑人、亚裔和其他少数族裔男性遭受性别暴力、寻求帮助行为及心理社会干预的经历:一项系统性综述

Ike, Tarela Juliet; Jidong, Dung Ezekiel; Carthy, Nikki; Nwanzu, Chiyem Lucky; Gair, Laura; Obi, Callistar Kidochukwu; Ishioro, Bernard Ozofere; Ike, Mieyebi Lawrence; Ayobi, Evangelyn Ebi; Ike, Peremi Richmond; Mahmood, Tariq; Doghor, Rukevwe Francis

Synchronous Extensive-Stage Small Cell Lung Cancer and Multiple Myeloma Detected by Marked Hypergammaglobulinemia

通过显著高丙种球蛋白血症检测到同步发生的广泛期小细胞肺癌和多发性骨髓瘤

Fujimoto, Makoto; Yanagihara, Toyoshi; Ueno, Hiroki; Aoki, Mikiko; Hamasaki, Makoto; Isobe, Yasushi; Ebi, Noriyuki; Inoue, Hiroyuki; Fujita, Masaki

Towards resilience: investigating resources for enhancing climate resilience in health care facilities in low and middle-income countries. a scoping review

迈向韧性:调查提升中低收入国家医疗机构气候韧性的资源——一项范围界定综述

Haider, Zia; Rocklöv, Joacim; Berry, Peter; Jobanputra, Kiran; Ebi, Kristie L; Ngo, Tuan Anh; Schwerdtle, Patricia Nayna

Lethal Heat and Humidity Events

致命高温高湿事件

Zhou, Shuang; Wu, Yao; Liu, Yanming; Gao, Yuan; Yu, Pei; Xu, Rongbin; Chen, Gongbo; Ye, Tingting; Yu, Wenhua; Añel, Juan Antonio; Bi, Peng; Bone, Angie; Ebi, Kristie L; Gasparrini, Antonio; Hashizume, Masahiro; Jay, Ollie; Kim, Yoonhee; Perkins-Kirkpatrick, Sarah; Wei Lee, Jason Kai; Li, Tiantian; Lin, Shao; Madaniyazi, Lina; Park, Jinah; Petrakopoulou, Fontina; Seposo, Xerxes; Tobias, Aurelio; Li, Shanshan; Guo, Yuming

Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma.

靶向 SUMO 化可促进 cBAF 复合物的稳定,并破坏滑膜肉瘤中的 SS18::SSX 转录组。

Floros Konstantinos V, Fairchild Carter K Jr, Li Jinxiu, Zhang Kun, Roberts Jane L, Kurupi Richard, Paudel Durga, Xing Yanli, Hu Bin, Kraskauskiene Vita, Hosseini Nayyerehalsadat, Shen Shanwei, Inge Melissa M, Smith-Fry Kyllie, Li Li, Sotiriou Afroditi, Dalton Krista M, Jose Asha, Abdelfadiel Elsamani I, Hill Ronald D, Slaughter Jamie M, Shende Mayuri, Lorenz Madelyn R, Tanaka Noritaka, Kajino Taisuke, Nelson Mary L, Hinojosa Mandy R, Kehinde Victor A, Belvin Benjamin R, Sugiokto Febri G, Lai Zhao, Dimopoulos Alexandros C, Boikos Sosipatros A, Stamatouli Angeliki M, Lewis Janina P, Manjili Masoud H, Ebi Hiromichi, Valerie Kristoffer, Li Renfeng, Poklepovic Andrew, Koblinski Jennifer E, Siggers Trevor, Banito Ana, Dozmorov Mikhail G, Jones Kevin B, Radhakrishnan Senthil K, Faber Anthony C

Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy

利用 CD47 和免疫检查点抑制剂抑制 KRAS 可克服对 KRAS 和免疫检查点抑制剂联合疗法的内在耐药性。

Kentaro Hirade,Noritaka Tanaka,Taisuke Kajino,Yuta Adachi,Ryo Kimura,Hitomi Kasuya,Satoru Kisoda,Tze King Tan,Sho Hayakawa,Takahiko Sato,Shogo Yanase,Yoko Kitaura,Takamasa Yamamoto,Yuki Nishioka,Osamu Muto,Daisuke Muraoka,Teruaki Fujishita,Natsumi Kasuga,Kageaki Watanabe,Yoshihiko Sakata,Masahiro Aoki,Hirokazu Matsushita,Takaomi Sanda,Shinsuke Iida,Kohsuke Tsuchiya,Rui Yamaguchi,Hiromichi Ebi

Extreme heat: a global call to action

极端高温:全球行动呼吁

Rakesh, Ankur; Sreedharan, Rajesh; Shumake-Guillemot, Joy; Jacob, Daniela; Murray, Virginia; Ebi, Kristie

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors: 1-Year Follow-Up of the FIRST-Dx Study

既往未接受治疗的晚期实体瘤的一线基因组分析:FIRST-Dx 研究的 1 年随访

Matsubara, Junichi; Mukai, Kumi; Kondo, Tomohiro; Yoshioka, Masahiro; Kage, Hidenori; Oda, Katsutoshi; Ikeda, Sadakatsu; Ebi, Hiromichi; Muro, Kei; Kajiura, Shinya; Hayashi, Ryuji; Ashida, Reiko; Kitano, Masayuki; Muto, Manabu

Mechanisms of Resistance to KRAS Inhibitors: Cancer Cells' Strategic Use of Normal Cellular Mechanisms to Adapt

KRAS抑制剂耐药机制:癌细胞策略性地利用正常细胞机制进行适应

Tanaka, Noritaka; Ebi, Hiromichi